ORIGINAL ARTICLE

Int. J. Public Health, 15 December 2023

Volume 68 - 2023 | https://doi.org/10.3389/ijph.2023.1606368

A Cross-Sectional Study of the Prevalence and Determinants of Common Mental Health Problems in Primary Care in Switzerland

  • 1. Department of Family Medicine, University Center of General Medicine and Public Health, Lausanne, Switzerland

  • 2. Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland

  • 3. Department of Ambulatory Care and Community Medicine, University Center of General Medicine and Public Health, Lausanne, Switzerland

Article metrics

2

Citations

2,1k

Views

808

Downloads

Abstract

Objective: This study investigated the prevalence of the most common mental health symptoms in a large primary care patient population and characterized their determinants.

Methods: Data came from a 2015–16 cross-sectional study of a primary care population in Switzerland. An investigator presented the study to patients in waiting rooms, and 1,103 completed a tablet-based questionnaire measuring stress in daily life, sleep disorders and anxiety and depressive symptoms. Diagnoses and treatments were recorded.

Results: Moderate-to-high anxiety and depressive symptoms concerned 7.7% of patients; 27.6% felt stressed at least once a week; 17.2% had severe sleep disorders. Sociodemographic determinants were associated with psychiatric symptoms: female sex, young age, and frequency of consultations with a GP. Participants taking psychotropics had high levels of mental distress.

Conclusion: Even though most patients were regularly monitored by their GP, a significant number of mental health problems were found. GPs should be provided with concrete tools to manage these patients better. Collaboration with mental health specialists should be encouraged in primary care settings.

Introduction

Mental health problems put significant burdens on patients, families, and healthcare systems more broadly. In Europe in 2011, the most prevalent 12 months disorders were anxiety disorders (14.0%), mood disorders (7.8%), especially major depression (6.9%), and insomnia (7.0%) [1]. A 2022 World Health Organization report ranked depressive disorders as the second largest contributor to non-fatal declining health worldwide, responsible for 5.6% of all Years Lived with Disability (YLD); anxiety disorders were the sixth-largest contributor (3.4% of all YLD) [2]. The 2017 Global Burden of Disease study found that 13.9% of all the Disability-Adjusted Life Years lost in Switzerland were caused by mental health problems [3, 4].

In primary care contexts, which is mainly represented by general practitioners (GPs) practices, many of these disorders are not properly diagnosed or are poorly treated because GPs sometimes feel that they lack the skills to treat mental health problems and cannot offer their patients enough consultation time for these problems [510]. Additionally, despite some GPs not having the proper screening tools to detect mental health problems [7], they are often the first healthcare professionals to be in contact with these patients, before any specialists [7, 11, 12]. A prevalence of 25%–60% of mental disorders in primary care medicine has been reported worldwide [13, 14]. In a study conducted in 2008–2009 in Switzerland, GPs estimated that 30% of their patients presented with symptoms of depression [15]. And they often have to take care of patients with mental health problems over the long term [7].

In 2020, the Swiss Health Observatory used Swiss Health Survey and other national survey data to reveal that 15.1% of Switzerland’s population reported having moderate-to-severe psychological distress. This indicator was measured using the Mental Health Inventory-5, which investigates the frequency with which patients have felt three negative emotional states (nervousness, bad mood, discouragement) and two positive emotional states (calm or peacefulness, feelings of happiness) in the past 4 weeks [16]. Scores do not necessarily equate to a medical diagnosis, but higher levels of self-reported psychological distress are linked to increased probabilities of presenting with a mental disorder. More than a third of respondents, for example, reported having mild-to-severe symptoms of depression (3% severe; 6% moderate; 26% mild) [3].

However, statistics are missing about the prevalence of GP consultations for common mental health problems. The data in most prevalence studies are derived from surveys conducted among the general population, and the links with primary care are not well explored. It means that the use of primary care in these surveys is not investigated. The present study used data collected directly from patients monitored by a GP. This study’s findings could, therefore, help GPs anticipate and target screenings and assist other stakeholders in proposing more optimal public health policies.

We know that there are many social determinants of mental health, which is why we choose different variables likely to be associated with mental health disorders in our study. The indicators we use in the analysis models have not been chosen randomly, but based on the literature. It has been shown, for example, that a person’s socio-economic level can influence his or her mental health [1719]. Demographic indicators such as gender or age are also important to take into account, in order to stratify the population studied and according to the results [20, 21]. This makes it possible to better target certain populations affected by one disorder or another in prevention initiatives for example. Certain health behaviours or lifestyle habits may also be associated with poor or good mental health, such as alcohol consumption, smoking or physical activity [22]. In the spirit of holistic care, we do not want to focus only on the medical aspect and symptomatology. Looking at the patient’s lifestyle and environment seems important to better understand the mental health disorders encountered in family medicine.

The present study’s primary objective was to determine the prevalence of the most common mental health problems (depression, anxiety, sleep disorders, and stress) in a large primary care patient population and characterize their determinants. Its secondary objective was to observe whether mental health problems were associated with patients’ self-reported psychiatric diagnoses and psychotropic treatments.

Methods

Data came from a survey conducted for the Swiss Primary care Active Monitoring (SPAM-Prev) program on prevention in family medicine in Switzerland [23, 24]. In 2012, the SPAM research network began collecting data for several studies involving family medicine and was constituted of GPs willing to be part of the network.

The present study is a national, cross-sectional survey conducted in 2015–16 by the University Center for Primary Care and Public Health’s Department of Family Medicine (formerly the University Medical Polyclinic) in Lausanne. Its objective was to monitor primary care activities and professionals in Switzerland. We had a 60% participation rate: 170 GPs from the SPAM network participated in this study, representativeness was verified on the basis of sex, gender and region [25]. These GPs asked their patients to participate too. A trained investigator was assigned to each medical practice to administer a questionnaire to up to 10 patients using a tablet computer. A total of 1,157 patients were included (a mean of about 7 patients per GP), and data on sociodemographic variables, patients’ perceptions of their health and their opinions about prevention were investigated. Their use of care, medical history, and treatments were also obtained.

The study was approved by the Human Research Ethics Committee of the Canton of Vaud (N°74/15), and all patients signed a written informed consent form.

Data

For the present study, we selected nine items from the SPAM questionnaire about mental health:

  • - The Patient Health Questionnaire-4 (PHQ-4) is a four-item questionnaire on anxiety and depression combining a two-item measure (PHQ-2) of the core criteria for depression and a two-item measure for anxiety (Generalized Anxiety Disorder 2-item or GAD-2), both of which have been independently shown to be good, brief screening tools [2628]. A PHQ-2 is positive if the score is equal or superior to 3 points, situation in which we consider the patient to have a high probability to have a major depression or another depressive trouble [29]. A GAD-2 is positive if the score is equal or superior to 3 points, situation in which we consider the patient to have a high probability to have one of the following issues: generalized anxiety disorder, panic disorder, social anxiety disorder or posttraumatic stress disorder [28]. The PHQ-4 is used to identify individuals at risk of anxiety and/or depressive disorders, and the score is distributed as follows: 0–2 points: normal risk, 3–5 points: mild risk, 6–8 points: moderate risk, 9–12 points: severe risk [26].

  • - The frequency of exposure to stress was measured by the question “Do you feel stressed in your daily life?” The three possible answers were “never,” “occasionally,” and “often (1/week) or very often (>1/week)”.

  • - A sleep quality score was based on four questions: “Generally, do you have difficulties falling asleep?”; “Do you ever wake up during the night and have difficulties falling asleep again?”; “Do you ever wake up too early in the morning without being able to fall asleep again?” and “Generally, do you evaluate your sleep as being regenerative, meaning that it enables you to recover from the fatigue of the day?” ([3032]). Each positive answer to the first three questions and each negative answer to the last question added one point to the final score, resulting in four categories: 0 = no sleep disorders, 1 = mild sleep disorder, 2 = moderate sleep disorder, and 3 or 4 points = severe sleep disorder.

We also used data on medical diagnoses and treatments self-reported by patients:

  • - Diagnosed medical conditions or disorders self-reported by patients in answer to the question “Do you have any chronic illnesses? If so, which one?” were coded using the International Classification of Diseases 10th revision (ICD-10). We retained all the self-reported diagnoses concerning mental health (F00–F99 mental health and behavioral disorders).

  • - Medications were coded using the Anatomical Therapeutic Chemical (ATC) classification system). We retained all the antipsychotics, anxiolytics, hypnotics and sedatives, antidepressants, and psychostimulants (N05 and N06).

Statistical Analysis

We began by making a descriptive analysis of the participants’ sociodemographic characteristics, their self-reported psychiatric diagnoses and psychotropic treatments and some of their health behaviors. We then described patients’ mental health status based on their self-reported psychiatric diagnoses and psychotropic treatments, the PHQ-4’s items on anxiety and depression, and their self-reported frequency of exposure to stress and the severity of sleep disorders. Finally, the associations between these three main indicators (PHQ-4, exposure to stress and severity of sleep disorders) and patients’ sociodemographic, health-related, and lifestyle-related variables were analyzed using ordered logistic regressions (appropriate model for ordinal categorical data). The sociodemographic variables included were sex, age (studied in a quantitative or categorial mode, depending on the model’s performance), country of birth, family status, educational level (vocational training is equivalent to apprenticeship or high school level, and higher education means a degree superior to high school), and employment status. Health-related variables were perceived health (scored on a scale from 0 to 100), the number of consultations with a GP in the last 12 months, and body mass index (BMI = weight [kg]/height2 [m2]). Lifestyle-related variables were tobacco use, alcohol consumption (AUDIT-C) [33, 34], cannabis use, playing sports, and eating habits. We performed univariate and multivariate analyses to investigate which factors (independent sociodemographic, health-related, and lifestyle-related variables) were predictive of the three indicators (mental health-related dependent variables). In our univariate analyses, variables associated with a p-value of ≤0.2 were selected to build three final multivariate models using manual stepwise selection (removal of the least significant variable at each step). Statistical analyses were performed using STATA software (Version 14.2).

Results

The sociodemographic, health, and lifestyle characteristics of the 1,103 patients included in the study are described in Table 1. The difference from the original number of participants was due to 54 patients for whom we only had information about treatment and diagnosis, so they were excluded from the analyses. Mean patient age was 58 years old, 56.6% were women, 40.3% were in employment, and 44.2% were retired. Participants’ mean perceived health score was 70.6, 2.4% reported one or more psychiatric diagnoses, and 6% were taking a psychotropic treatment. The distribution of the psychotropic drugs taken is shown in Table 1. Of the patients diagnosed with a psychiatric disorder, 32.1% were taking a psychotropic treatment.

TABLE 1

n (N = 1,103) %
Sex
Male 479 43.5
Female 623 56.5
Age
15–34 156 14.4
35–49 179 16.5
50–65 266 24.5
>65 484 44.6
Country of birth
Switzerland 830 75.3
Other 273 24.7
Employment status
Employed 424 40.3
Retired 465 44.2
Student/Apprentice 41 3.9
Unemployed/Inactive 121 11.5
Educational level
Obligatory schooling or less 190 18.1
Vocational training 568 53.9
Higher education 295 28.0
Family status
Couple (with children) 232 21.1
Couple (no children) 455 41.3
Living alone with children 46 4.2
With parents 62 5.6
Living alone 306 27.8
Perceived health score (scale from 0 to 100)
0–55 281 25.6
56–80 433 39.4
81–90 229 20.9
91–100 155 14.1
Body Mass Index
Underweight (<18.5 kg/m2) 25 2.6
Normal (>18.5<25 kg/m2) 422 43.2
Overweight (>25<30 kg/m2) 308 31.5
Obese (>30 kg/m2) 222 22.7
Self-reported psychiatric diagnosis
Yes 27 2.4
No 1,073 97.6
Psychotropic treatment
Yes 66 6.0
Type of medicationa
Antidepressant 45 4.1
Antipsychotic 7 0.6
Anxiolytic 22 2.0
Others 4 0.4
No 1,034 94.0
Consultations with a GP in the last 12 months
0 78 7.01
1–2 290 26.3
3–5 343 31.1
>6 392 35.5
Tobacco use
Yes 235 21.4
No 865 78.6
Hazardous alcohol consumption (audit-c)
Yes 391 35.5
No 711 64.5
Cannabis use (last 30 days)
Yes 51 4.70
No 1,043 95.3
Sports frequency
Very often (>1/week) 370 33.8
Often (1/week) 207 18.9
Occasionally 218 19.9
Never 300 27.4
Balanced diet
Yes 902 82.7
No 153 14.0
Does not know 36 3.3

Sample characteristics (Lausanne, Switzerland. 2021).

a

Some patients were undergoing more than one psychotropic treatment; thus, we have a sum greater than 6%.

The largest group (43.6%) of patients reported never being stressed during their daily life, 28.8% were occasionally stressed, and 27.6% were often (1/week) or very often (>1/week) stressed. Concerning the PHQ-4, 19.1% showed mild symptoms of anxiety and depression, and 7.7% showed a moderate-to-high score: 9.7% of patients had a positive GAD-2 score, and 10.5% had a positive PHQ-2. Regarding sleep disorders, 28.7% of patients reported having general difficulties falling asleep, 36.6% sometimes woke up during the night and had difficulties falling asleep again, 30.2% sometimes awoke too early in the morning without being able to fall asleep again, and 21.5% estimated that they did not get regenerative sleep. In total, more than half (58.1%) had one or more of these sleep issues. Overall, patients with a self-reported psychiatric diagnosis felt more frequently exposed to stress, had a higher PHQ-4 score, and had more severe sleep disorders. The same tendency was observed among participants taking psychotropic drugs (Table 2).

TABLE 2

All patients N (%) Patients with a psychiatric diagnosis Patients undergoing a psychotropic treatment
Patient Health Questionnaire-4 Normal 758 (73.2%) 10 (37%) 25 (38.5%)
Mild 198 (19.1%) 7 (25.9%) 23 (35.4%)
Moderate/Severe 80 (7.7%) 10 (37%) 17 (26.1%)
Stress frequency Never 481 (43.6%) 5 (18.5%) 23 (34.9%)
Occasionally 318 (28.8%) 13 (48.2%) 22 (33.3%)
Often/very often (>1/week) 304 (27.6%) 9 (33.3%) 21 (31.8%)
Sleep disorders No 432 (41.9%) 4 (14.8%) 18 (28.1%)
Mild 243 (23.5%) 10 (37%) 14 (21.9%)
Moderate 188 (17.4%) 4 (14.8%) 15 (23.4%)
Severe 177 (17.2%) 9 (33.4%) 17 (26.6%)

Mental health-related variables: symptom, self-reported diagnosis, and psychotropic treatment frequencies (%) (Lausanne, Switzerland. 2021).

The variables associated with the frequency of exposure to stress are provided in Table 3. In the final multivariate analysis model, females were twice as likely to be stressed as males (OR = 2.09 [1.63–2.69]). Less frequent stress was associated with older age, especially among participants older than 65 (OR = 0.42 [0.22–0.79]), a high level of perceived health (OR = 0.995 [0.98–1.00], and a balanced diet (OR = 0.55 [0.38–0.78]). A high frequency of exposure to stress was associated with cannabis use (OR = 2.16 [1.18–3.96]), physical inactivity (OR = 1.47 [1.06–2.03]), regular sport practice (once a week) (OR = 1.44 [1.02–2.03]), and even more to an occasional sport practice (OR = 1.64 [1.16–2.32]) compared to a very frequent (more than once a week) practice. A lower frequency of exposure to stress was associated with people living in couple without children (OR = 0.68 [0.49–0.95]), alone with children (OR = 0.52 [0.28–0.97]) or alone without children (OR = 0.58 [0.41–0.83]) compared to couples with children or people living with their parents.

TABLE 3

Univariate analyses Multivariate analyses
n % OR 95% CI OR 95% CI
Sex (ref: Male)
Female 623 56.5 1.81 1.44–2.26 2.09 1.63–2.69
Age (ref: 15–34)
35–49 179 15.7 0.82 0.55–1.21 0.76 0.48–1.20
50–65 266 23.4 0.59 0.41–0.85 0.65 0.42–1.01
>65 538 47.2 0.31 0.22–0.44 0.42 0.22–0.79
Country of birth (ref: Switzerland)
Other 273 24.7 1.36 1.06–1.76 - -
Employment status (ref: Employed)
Retired 465 44.24 0.28 0.22–0.37 0.56 0.32–0.96
Student/Apprentice 41 3.9 1.01 0.56–1.85 0.65 0.32–1.34
Unemployed/Inactive 121 11.5 1.11 0.77–1.61 0.99 0.67–1.47
Educational level (ref: Obligatory schooling or less)
Vocational training 568 53.9 1.11 0.81–1.51 - -
Higher education 295 28 1.44 1.03–2.03 - -
Family status (ref: Couple (with children)/With parents)
Couple (no children) 455 41.3 0.42 0.32–0.55 0.68 0.49–0.95
Living alone with children 46 4.2 0.66 0.37–1.16 0.52 0.28–0.97
Living alone 306 27.8 0.46 0.34–0.62 0.58 0.41–0.83
Perceived health score (scale from 0 to 100, continuous variable)
1,098 100 0.995 0.99–0.999 0.995 0.98–1.00
Body Mass Index (ref: Normal and underweight (<25 kg/m2))
Overweight (>25<30 kg/m2) 308 31.5 0.91 0.69–1.19 - -
Obese (>30 kg/m2) 222 22.7 1.19 0.88–1.61 - -
Self-reported psychiatric diagnosis (ref: No)
Yes 28 2.4 1.79 0.94–3.43 - -
Psychotropic treatment (ref: No)
Yes 68 5.9 1.28 0.82–1.99 - -
Consultations with a GP in the last 12 months (ref: 0)
1–2 290 25.1 1.10 0.69–1.76 - -
3–5 343 29.7 0.88 0.55–1.40 - -
>6 446 38.5 1.32 0.84–2.08 - -
Tobacco use (ref: No)
Yes 235 21.4 1.51 1.16–1.98 - -
Hazardous alcohol consumption (audit-c) (ref: No)
Yes 391 35.5 1.21 0.96–1.52 - -
Cannabis use (last 30 days) (ref: No)
Yes 51 4.7 2.96 1.74–5.05 2.16 1.18–3.96
Sports frequency (ref: Very often (>1/week))
Often (1/week) 207 18.9 1.35 0.99–1.84 1.44 1.02–2.03
Occasionally 218 19.9 1.78 1.30–2.43 1.64 1.16–2.32
Never 300 27.4 1.03 0.77–1.37 1.47 1.06–2.03
Balanced diet (ref: No)
Yes 938 86 0.42 0.31–0.58 0.55 0.38–0.78

Patient characteristics associated with perceived frequency of stress (ordered logistic regression) (Lausanne, Switzerland. 2021).

Results in bold are significant.

In the final multivariate analysis model, a higher PHQ-4 score was associated (but was barely significant) with female sex (OR = 1.31 [0.97–1.77]) and being born outside Switzerland (OR = 1.6 [1.16–2.21]). It was also associated with high numbers of consultations with a GP in the last 12 months (OR = 1.78 [1.14–2.77]), low levels of perceived health (OR = 0.99 [0.98–0.99], physical inactivity (OR = 2.05 [1.38–3.04]), and employment status: unemployed patients (job seekers or those receiving invalidity insurance payments, etc.) were more likely to score high on the PHQ-4 scale (OR = 1.78 [1.14–2.77]) than patients in employment. Lower PHQ-4 scores were associated with older age (OR = 0.98 [0.97–0.99], a continuous variable) and a balanced diet (OR = 0.57 [0.38–0.83]) (Table 4).

TABLE 4

Univariate analyses Multivariate analyses
n % OR 95% CI OR 95% CI
Patients 1,157
Sex (ref: Male)
Female 591 57.1 1.39 1.05–1.84 1.31 0.97–1.77
Age (continuous variable)
1,019 0.99 0.98–0.99 0.98 0.97–0.99
Country of birth (ref: Switzerland)
Other 255 24.6 1.72 1.27–2.32 1.60 1.16–2.21
Employment status (ref: Employed)
Retired 442 43.7 0.81 0.60–1.11 1.09 0.66–1.84
Student/Apprentice 41 4 1.00 0.49–2.06 0.98 0.43–2.26
Unemployed/Inactive 119 11.8 2.31 1.52–3.5 1.78 1.14–2.77
Education level (ref: Obligatory schooling or less)
Vocational training 540 53.3 0.68 0.48–0.97 - -
Higher education 288 28.4 0.61 0.41–0.92 - -
Family status (ref: Couple with children/With parents)
Couple (no children) 421 40.7 0.69 0.50–0.99 0.82 0.55–1.24
Living alone with children 45 4.4 1.87 1.01–3.46 1.98 1.02–3.84
Living alone 291 28.1 1.10 0.74–1.51 1.06 0.69–1.62
Perceived health score (scale from 0 to 100, continuous variable)
1,034 0.98 0.98–0.99 0.99 0.98–0.99
Body Mass Index (ref: Normal or underweight (<25 kg/m2))
Overweight (>25 < 30 kg/m2) 291 31.7 1.69 1.20–2.37 - -
Obese (>30 kg/m2) 211 22.9 1.61 1.11–2.32 - -
Self-reported psychiatric diagnosis (ref: No)
Yes 27 2.6 6.1 2.91–12.77 - -
Psychotropic treatment (ref: No)
Yes 65 6.3 4.97 3.08–8.01 - -
Consultations with a GP in the last 12 months (ref: 0)
1–2 279 26.9 1.43 0.73–2.82 1.43 0.70–2.90
3–5 328 31.7 1.71 0.88–3.31 1.85 0.92–3.71
>6 355 34.3 2.80 1.46–5.39 2.59 1.30–5.18
Tobacco use (ref: No)
Yes 224 21.6 1.41 1.02–1.94 - -
Hazardous alcohol consumption (audit-c) (ref: No)
Yes 362 35 0.84 0.63–1.12 - -
Cannabis use (last 30 days) (ref: No)
Yes 49 4.7 1.83 1.02–3.26 - -
Sports frequency (ref: Very often (>1/week))
Often (1/week) 199 19.2 1.49 0.99–2.24 1.67 1.08–2.59
Occasionally 205 19.8 1.88 1.26–2.80 1.58 1.04–2.42
Never 280 27 1.29 1.60–3.28 2.05 1.38–3.04
Balanced diet (ref: No)
Yes 888 85.8 0.44 0.31–0.62 0.57 0.38–0.83

Patient characteristics associated with Patient Health Questionnaire-4 score (ordered logistic regression) (Lausanne, Switzerland. 2021).

Results in bold are significant.

In the final multivariate analysis model, a higher risk of reported sleep disorder was associated with female sex (OR = 1.34 [1.06–1.69]) and more consultations with a GP in the last 12 months (OR = 1.69 [1.03–2.78]). Factors associated with fewer sleep disorders were a good perceived health (OR = 0.99 [0.98–0.99]) and educational level: vocational training (OR = 0.72 0.52–0.99) compared to obligatory schooling or less. No associations with age were revealed, but we maintained this variable in the final model to ensure overall coherence (Table 5).

TABLE 5

Univariate analyses Multivariate analyses
n % OR 95% CI OR 95% CI
Sex (ref: Male) 1,157
Female 578 56.1 1.33 1.06–1.67 1.34 1.06–1.69
Age (ref: 15–34)
35–49 172 16.9 0.98 0.65–1.46 0.97 0.65–1.47
50–65 246 24.2 1.29 0.89–1.86 1.22 0.83–1.78
>65 451 44.4 0.92 0.66–1.30 0.83 0.58–1.18
Country of birth (ref: Switzerland)
Other 256 24.8 1.20 0.92–1.55 - -
Employment status (ref: Employed)
Retired 443 43.8 0.93 0.73–1.18 -
Student/Apprentice 41 4.1 0.98 0.54–1.77 -
Unemployed/Inactive 116 11.5 1.32 0.91–1.92 -
Educational level (ref: Obligatory schooling or less)
Vocational training 548 54.2 0.68 0.49–0.92 0.72 0.52–0.99
Higher education 283 28 0.64 0.45–0.90 0.77 0.53–1.10
Lifestyle (ref: Couple (children)/With parents))
Couple (no children) 427 41.4 1.03 0.78–1.36 - -
Living alone with children 46 4.5 1.46 0.84–2.55 - -
Living alone 281 27.3 1.13 0.83–1.53 - -
Perceived health score (scale from 0 to 100, continuous variable)
1,029 100 0.99 0.98–0.99 0.99 0.98–0.99
Body Mass Index (ref: Underweight or normal (<25 kg/m2))
Overweight (>25<30 kg/m2) 283 31 1.19 0.91–1.57 - -
Obese (>30 kg/m2) 211 23.1 1.15 0.85–1.56 - -
Self-reported psychiatric diagnosis (ref: No)
Yes 27 2.6 2.49 1.27–4.88 - -
Psychotropic treatment (ref: No)
Yes 64 6.2 1.91 1.21–3.01 - -
Consultations with a GP in the last 12 months (ref: 0)
1–2 280 27 1.21 0.74–1.97 1.13 0.69–1.86
3–5 320 31 1.48 0.91–2.42 1.42 0.87–2.34
>6 359 34.9 1.89 1.16–3.07 1.69 1.03–2.78
Tobacco use (ref: No)
Yes 218 21.1 1.28 0.97–1.68 - -
Hazardous alcohol consumption (audit-c) (ref: No)
Yes 366 35.5 1.08 0.86–1.36 - -
Cannabis use (last 30 days) (ref: No)
Yes 47 4.6 1.36 0.79–2.35 - -
Sports frequency (ref: Very often (>1/week))
Often (1/week) 195 18.9 1.05 0.77–1.44 - -
Occasionally 202 19.6 1.11 0.81–1.52 - -
Never 284 27.5 0.92 0.69–1.23 - -
Balanced diet (ref: No)
Yes 887 86 0.70 0.51–0.96 - -

Patient characteristics associated with sleep disorders (ordered logistic regression) (Lausanne, Switzerland. 2021).

Results in bold are significant.

Discussion

The present study’s findings underlined the presence of significant mental distress among a primary care patient population: 27.6% were often (1/week) or very often (>1/week) stressed, 7.7% had a moderate-to-high PHQ-4 score and 53% were touched by at least one of the four sleep disorder criterias. Nevertheless, only 2.4% of participants reported being diagnosed with a psychiatric disorder. The PHQ-4 is a validated, widely-used screening tool, and a high score frequently leads to a diagnosis of depression or anxiety [19, 25]. However, we observed that these self-reported diagnoses were less frequent than reported mental health problems would suggest. In comparison, we can cite the OBSAN report about mental health in Switzerland, in which we see that in 2017, 15.1% of Switzerland’s population reported a moderate-to-high psychological distress [3]. Our finding could signal that mental health problems are under-diagnosed and may explain some of the under-treatment that we observed. In the general population of Switzerland, according to the OBSAN report already cited, during the 12 months preceding the survey of 2017, 5.4% of the participants had been diagnosed with a depression [3]. Concerning anxiety disorders, the global 12 months prevalence is 7.3%, which is way more than the reported diagnoses in our study [4].

Even if a pharmacological treatment is not always needed, we can observe that two thirds (67.9%) of patients with a self-reported psychiatric diagnosis were not being treated pharmacologically, and patients with a self-reported psychiatric diagnosis and/or undergoing psychotropic treatment were still very much affected by psychological suffering. For example, 26% of people treated with a psychotropic drug had a moderate-to-high PHQ-4 score. Our results showed that GPs need to better integrate mental healthcare into their daily practice, for example, by using screening scores to detect mental health problems or by integrating closer monitoring after initiating a psychotropic drug to evaluate symptom evolution and consequently adapt the medication. These findings should also encourage GPs and other stakeholders in the healthcare system to reflect more broadly on mental health and imagine new ways to improve primary care monitoring and follow-up for patients with mental health problems.

We found common determinants for the mental health problems among our specific sample and among the general population: poor mental health was associated with female sex, a low educational level (associated with sleep disorders in our study), and unemployment (associated with PHQ-4 in our study) [17, 18]. These three social indicators were also associated with high PHQ-4 scores in other studies, e.g., the German and Colombian general populations [27, 35]. For example, unemployment’s associations with poorer physical and mental health have been well described, due to, among other things, financial stress and the lack of the social status awarded to people in work [19, 36]. It should be noted, however, that people affected by such social determinants often feel oppressed, and it may be this that makes them vulnerable in terms of mental health rather than being unemployed per se [18].

The finding that female sex was associated with a higher frequency of stress and more sleep disorders was consistent with the existing literature. Various hypotheses have been put forward about this difference, such as women’s tendency to report their psychological symptoms more easily than men. The medicalization of women’s mental health could also lead to over-diagnosis among them and, conversely, under-diagnosis among men [20]. Moreover, diagnostic and screening methods may not necessarily have been adapted to women, and some sex differences have been seen to depend on the scales used [21]. Regarding depression–even if female sex is not associated with PHQ-4 score in our study - we can cite a recent study who revealed a new genetic clue to the higher rates of depression among women: a specific, non-coding RNA strand that can be upregulated in some women suffering from depression [37]. Links between mental health and sex need to be investigated further.

We noted an association between patients with more symptoms of depression and/or anxiety (higher PHQ-4 scores) and more sleep disorders tended to have consulted their GP more frequently in the last 12 months. One of the reason for this, is that many of these patients have a chronic or somatic disorder, and it is known that there is a high comorbidity between these and mental health problems [38]. GPs should, therefore, deliberately explore potential mental health issues among patients who consult very frequently, regardless of their reason for doing so. In addition, the active detection of mental health problems can be a valuable part of suicide risk prevention [39, 40]. We could also consider these results from another angle: close medical follow-up—as revealed by high numbers of consultations with a GP—is necessary for patients with mental health problems. In this context, GPs have a central role to play in creating robust physician–patient relationships and providing therapeutic support [41, 42].

Managing patients with mental health problems is a major challenge for GPs, and knowing when to refer patients to a mental health specialist is part of this task [43]. GPs must, therefore, be conscious of their professional and personal competencies and limitations, defining which situations require the intervention of a psychologist, a psychiatrist, or another mental health specialist. In Switzerland, an internship in a psychiatric hospital or institution is not mandatory for GP residents. Future GPs should be encouraged to do some clinical psychiatry before opening their practices, in order to acquire specific psychiatric skills, better refer patients to mental health specialists, and better collaborate with them [44]. In addition, prevention and public health are rarely addressed during medical school in Switzerland, as it is mainly focused on individual medicine. To develop a more global or community vision of health, future physicians should be made more aware of these subjects. In parallel, it would be interesting to explore the possibilities for interprofessional collaboration between GPs and mental health specialists. In other countries, some GPs work directly with mental health specialists in the same practice [45, 46]. In Switzerland, having a psychiatrist in a group practice has been tested, and the use of such practice configurations needs to be expanded [47].

Finally, we should not forget the GP’s role as a health promoter [48]. The present study found associations between physical activity, a balanced diet, and the absence of tobacco use and better mental health—associations that have been well demonstrated in previous studies [22, 49]. Some GPs prescribe walks or other physical activities in nature, and this has been shown to have an impact on mental health, especially when associated with contact with biodiversity [50, 51]. Taking the time for physical and mental health prevention activities during consultations is a major role of GPs in primary care [23, 24]. Screening tools such as the PHQ-4 can easily be used in this context, and other scores could be developed specifically for GPs. For example, without a validated tool to identify sleep disorders, a GP could use the four screening questions used in the present study.

Strengths and Limitations

One of our study’s strengths is that it was carried out within a specific population monitored by GPs: the prevalence of mental health problems is usually studied within the general population. As GPs play a central role in treating mental health, conducting studies about this specific population seems important. Regarding patients with a self-reported psychiatric diagnosis or undergoing psychotropic treatment, we remained unaware of whether they were benefitting from psychiatric or psychotherapeutic monitoring or whether their psychotropic treatment was prescribed by a GP or another healthcare professional. It would be interesting to explore the links and types of collaboration between GPs and psychiatrists and other mental health specialists in primary care settings, to help us better understand how to optimize those collaborations and in which situations patients are referred to a specialist [52]. For example, GPs in Italy are more likely to refer their patients to a mental health specialist than GPs in France [12].

The present study’s results were based on a few questions selected from a much larger preventive healthcare survey, thus limiting the depth of our investigation into each subtopic. Future primary care studies should ask additional specific questions about mental health together with more in-depth investigations from a qualitative perspective.

The existence of a recall bias should be mentioned. Patients tend to remember their treatments more easily than their diagnoses. In addition, some psychotropic treatments can be given without a medical diagnosis. These two elements could explain some of the difference between the number of psychotropic treatments and self-reported psychiatric diagnoses recorded.

With regard to the score used to detect sleep disorders, we considered that one positive response or more was already considered a sleep disorder. This runs the risk of overestimating the sleep disorders actually present in patients.

Another important point is that we had no access to data related to non-pharmacological treatments. This limits any interpretation of the relationship between a psychotropic treatment and a participant’s symptomatology. Indeed, a pharmacological treatment alone is often insufficient, in many cases, it should be accompanied by psychotherapy. And in many situations, especially when the mental health problem is mild, the patient is sufficiently helped with psychotherapy or counseling, and pharmacological treatment is thus not always needed.

In the same idea, we did not have any data about the social support the patients had in their life. Indeed, a lot of studies have demonstrated the significant impact of social support on mental health, so it would be interesting to have this kind of information for more complete analyzes [18, 19].

The fact that the data utilized in this study were collected in 2015–16 is a limitation. The results do not take account of recent developments in the field. It’s also worth noting that the COVID-19 epidemic changed a lot in terms of mental health too, and if we were to redo the data collection today, the results would probably not be the same [53].

Finally, the study’s transversal design meant that we could not establish any causal links, only associations, thus limiting any interpretations of our results.

Conclusion

Our study showed that a significant number of general practitioners’ (GPs) patients experience psychological symptoms and that specific social determinants are strongly associated with poor mental health. By identifying these determinants, GPs could monitor their patients more closely and better target screening. Indeed, mental health problems tend to be under-diagnosed in primary care settings. To provide patients with better care, GPs need to have a greater understanding of the distress caused by mental health problems and have the effective tools to manage them.

It is also important to know which patients to refer to a mental health professional and when their mental disorder may go beyond the usual scope of a GP’s skills. Better interprofessional collaboration in primary mental healthcare in Switzerland needs to be developed and implemented in order to improve overall healthcare provision.

GPs play a crucial role in their patients’ mental health. It is an integral part of their profession, in terms of prevention, treatment, and follow-up. Overall, mental health services must be better integrated into primary healthcare provision in order to provide patients with more comprehensive care.

Statements

Ethics Statement

The studies involving humans were approved by the Human Research Ethics Committee of the Canton of Vaud (N°74/15). The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.

Author Contributions

JM performed the statistical analyses. CC was the senior supervisor of the study. JM, CC and KT wrote the main manuscript text. All the authors discussed the results, read, and approved the final manuscript.

Conflict of Interest

The authors declare that they do not have any conflicts of interest.

References

  • 1

    Wittchen HU Jacobi F Rehm J Gustavsson A Svensson M Jönsson B et al The Size and Burden of Mental Disorders and Other Disorders of the Brain in Europe 2010. Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol (2011) 21(9):65579. 10.1016/j.euroneuro.2011.07.018

  • 2

    World Mental Health Report. World Mental Health Report (2023). Available from: https://www.who.int/teams/mental-health-and-substance-use/world-mental-health-report (Accessed January 13, 2023).

  • 3

    La santé psychique en Suisse. Moni-Torage 2020 (Obsan Rapport 15/2020) (2020).

  • 4

    Baxter AJ Scott KM Vos T Whiteford HA . Global Prevalence of Anxiety Disorders: A Systematic Review and Meta-Regression. Psychol Med (2013) 43(5):897910. 10.1017/S003329171200147X

  • 5

    Lech S Herrmann W Trautmann S Schwantes U Gellert P Behr J et al Depression in Primary Care and the Role of Evidence-Based Guidelines: Cross-Sectional Data From Primary Care Physicians in Germany. BMC Health Serv Res (2022) 22(1):1279. 10.1186/s12913-022-08631-w

  • 6

    Talbot A Lee C Ryan S Roberts N Mahtani KR Albury C . Experiences of Treatment-Resistant Mental Health Conditions in Primary Care: A Systematic Review and Thematic Synthesis. BMC Prim Care (2022) 23(1):207. 10.1186/s12875-022-01819-3

  • 7

    Kroenke K Unutzer J . Closing the False Divide: Sustainable Approaches to Integrating Mental Health Services Into Primary Care. J Gen Intern Med (2017) 32(4):40410. 10.1007/s11606-016-3967-9

  • 8

    Wakida EK Talib ZM Akena D Okello ES Kinengyere A Mindra A et al Barriers and Facilitators to the Integration of Mental Health Services into Primary Health Care: A Systematic Review. Syst Rev (2018) 7(1):211. 10.1186/s13643-018-0882-7

  • 9

    Mykletun A Knudsen AK Tangen T Overland S . General Practitioners’ Opinions on How to Improve Treatment of Mental Disorders in Primary Health Care. Interviews With One Hundred Norwegian General Practitioners. BMC Health Serv Res (2010) 10:35. 10.1186/1472-6963-10-35

  • 10

    Ayalon L Karkabi K Bleichman I Fleischmann S Goldfracht M . Barriers to the Treatment of Mental Illness in Primary Care Clinics in Israel. Adm Pol Ment Health (2016) 43(2):23140. 10.1007/s10488-015-0634-0

  • 11

    Senchyna A Abbiati M Chambe J Haller DM Maisonneuve H . General Practitioners’ Perspectives on Barriers to Depression Care: Development and Validation of a Questionnaire. BMC Fam Pract (2020) 21(1):156. 10.1186/s12875-020-01224-8

  • 12

    Kovess-Masfety V Alonso J Brugha TS Angermeyer MC Haro JM Sevilla-Dedieu C et al Differences in Lifetime Use of Services for Mental Health Problems in Six European Countries. Psychiatr Serv Wash DC (2007) 58(2):21320. 10.1176/ps.2007.58.2.213

  • 13

    Negus R . Seminars in Liaison Psychiatry, 2nd Edn. Clin Med (2013) 13(1):111. 10.7861/clinmedicine.13-1-111

  • 14

    World Health Organization. Doctors WO of F. Integrating Mental Health into Primary Care: A Global Perspective. WHO Press (2008). Available from: https://apps.who.int/iris/handle/10665/43935 (Accessed January 10, 2023).

  • 15

    OBSAN. La dépression dans la population suisse (2023). Available from: https://www.obsan.admin.ch/fr/publications/2013-la-depression-dans-la-population-suisse (Accessed January 13, 2023).

  • 16

    Veit CT Ware JE . The Structure of Psychological Distress and Well-Being in General Populations. J Consult Clin Psychol (1983) 51:73042. 10.1037//0022-006x.51.5.730

  • 17

    Allen J Balfour R Bell R Marmot M . Social Determinants of Mental Health. Int Rev Psychiatry (2014) 26(4):392407. 10.3109/09540261.2014.928270

  • 18

    Alegría M NeMoyer A Falgàs Bagué I Wang Y Alvarez K . Social Determinants of Mental Health: Where We Are and Where We Need to Go. Curr Psychiatry Rep (2018) 20(11):95. 10.1007/s11920-018-0969-9

  • 19

    Brydsten A Hammarström A San Sebastian M . Health Inequalities Between Employed and Unemployed in Northern Sweden: A Decomposition Analysis of Social Determinants for Mental Health. Int J Equity Health (2018) 17(1):59. 10.1186/s12939-018-0773-5

  • 20

    Bacigalupe A Martín U . Gender Inequalities in Depression/Anxiety and the Consumption of Psychotropic Drugs: Are We Medicalising Women’s Mental Health?Scand J Public Health (2021) 49(3):31724. 10.1177/1403494820944736

  • 21

    Salokangas RKR Vaahtera K Pacriev S Sohlman B Lehtinen V . Gender Differences in Depressive Symptoms: An Artefact Caused by Measurement Instruments?J Affect Disord (2002) 68(2):21520. 10.1016/s0165-0327(00)00315-3

  • 22

    Firth J Solmi M Wootton RE Vancampfort D Schuch FB Hoare E et al A Meta-Review of ‘Lifestyle Psychiatry’: The Role of Exercise, Smoking, Diet and Sleep in the Prevention and Treatment of Mental Disorders. World Psychiatry Off J World Psychiatr Assoc WPA (2020) 19(3):36080. 10.1002/wps.20773

  • 23

    Cohidon C Imhof F Bovy L Birrer P Cornuz J Senn N . Patients’ and General Practitioners’ Views About Preventive Care in Family Medicine in Switzerland: A Cross-Sectional Study. J Prev Med Public Health Yebang Uihakhoe Chi (2019) 52(5):32332. 10.3961/jpmph.19.184

  • 24

    Cohidon C Wild P Senn N . A Structural Equation Model of the Family Physicians Attitude Towards Their Role in Prevention: A Cross-Sectional Study in Switzerland. Fam Pract (2019) 36(3):297303. 10.1093/fampra/cmy063

  • 25

    Selby K Cornuz J Senn N . Establishment of a Representative Practice-Based Research Network (PBRN) for the Monitoring of Primary Care in Switzerland. J Am Board Fam Med (2015) 28(5):6735. 10.3122/jabfm.2015.05.150110

  • 26

    Kroenke K Spitzer RL Williams JBW Löwe B . An Ultra-Brief Screening Scale for Anxiety and Depression: The PHQ-4. Psychosomatics (2009) 50(6):61321. 10.1176/appi.psy.50.6.613

  • 27

    Löwe B Wahl I Rose M Spitzer C Glaesmer H Wingenfeld K et al A 4-Item Measure of Depression and Anxiety: Validation and Standardization of the Patient Health Questionnaire-4 (PHQ-4) in the General Population. J Affect Disord (2010) 122(1–2):8695. 10.1016/j.jad.2009.06.019

  • 28

    Plummer F Manea L Trepel D McMillan D . Screening for Anxiety Disorders With the GAD-7 and GAD-2: A Systematic Review and Diagnostic Metaanalysis. Gen Hosp Psychiatry (2016) 39:2431. 10.1016/j.genhosppsych.2015.11.005

  • 29

    Kroenke K Spitzer RL Williams JBW . The Patient Health Questionnaire-2: Validity of a Two-Item Depression Screener. Med Care (2003) 41(11):128492. 10.1097/01.MLR.0000093487.78664.3C

  • 30

    Beck F Léon C Pin-Le Corre S Léger D . Troubles du sommeil: Caractéristiques sociodémographiques et comorbidités anxiodépressives. Étude (Baromètre santé INPES) chez 14734 adultes en France. Rev Neurol (Paris) (2009) 165(11):93342. 10.1016/j.neurol.2009.01.046

  • 31

    Beck F Richard JB Léger D . Prévalence et facteurs sociodémographiques associés à l’insomnie et au temps de sommeil en France (15–85ans). Rev Neurol (Paris) (2013) 169(12):95664. 10.1016/j.neurol.2013.02.011

  • 32

    Sateia MJ . International Classification of Sleep Disorders-Third Edition: Highlights and Modifications. Chest (2014) 146(5):138794. 10.1378/chest.14-0970

  • 33

    World Health Organization Babor TF Higgins-Biddle JC Saunders JB Monteiro MG . AUDIT: The Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Health Care. Report No: WHO/MSD/MSB/01.6a. WHO Press (2001). Available from: https://apps.who.int/iris/handle/10665/67205 (Accessed January 13, 2023).

  • 34

    Bradley KA DeBenedetti AF Volk RJ Williams EC Frank D Kivlahan DR . AUDIT-C as a Brief Screen for Alcohol Misuse in Primary Care. Alcohol Clin Exp Res (2007) 31(7):120817. 10.1111/j.1530-0277.2007.00403.x

  • 35

    Kocalevent RD Finck C Jimenez-Leal W Sautier L Hinz A . Standardization of the Colombian Version of the PHQ-4 in the General Population. BMC Psychiatry (2014) 14:205. 10.1186/1471-244X-14-205

  • 36

    Tøge AG . Health Effects of Unemployment in Europe (2008-2011): A Longitudinal Analysis of Income and Financial Strain as Mediating Factors. Int J Equity Health (2016) 15:75. 10.1186/s12939-016-0360-6

  • 37

    Issler O van der Zee YY Ramakrishnan A Xia S Zinsmaier AK Tan C et al The Long Noncoding RNA FEDORA Is a Cell Type– and Sex-Specific Regulator of Depression. Sci Adv (2022) 8(48):eabn9494. 10.1126/sciadv.abn9494

  • 38

    Scott KM Lim C Al-Hamzawi A Alonso J Bruffaerts R Caldas-de-Almeida JM et al Association of Mental Disorders With Subsequent Chronic Physical Conditions: World Mental Health Surveys From 17 Countries. JAMA Psychiatry (2016) 73(2):1508. 10.1001/jamapsychiatry.2015.2688

  • 39

    Pearson A Saini P Cruz DD Miles C While D Swinson N et al Primary Care Contact Prior to Suicide in Individuals With Mental Illness. Br J Gen Pract (2009) 59(568):82532. 10.3399/bjgp09X472881

  • 40

    Ahmedani BK Simon GE Stewart C Beck A Waitzfelder BE Rossom R et al Health Care Contacts in the Year before Suicide Death. J Gen Intern Med (2014) 29(6):8707. 10.1007/s11606-014-2767-3

  • 41

    Thomas H Best M Mitchell G . Whole-Person Care in General Practice: The Doctor-Patient Relationship. Aust J Gen Pract (2020) 49(3):13944. 10.31128/AJGP-05-19-49502

  • 42

    Olaisen RH Schluchter MD Flocke SA Smyth KA Koroukian SM Stange KC . Assessing the Longitudinal Impact of Physician-Patient Relationship on Functional Health. Ann Fam Med (2020) 18(5):4229. 10.1370/afm.2554

  • 43

    Tzartzas K Oberhauser PN Marion-Veyron R Bourquin C Senn N Stiefel F . General Practitioners Referring Patients to Specialists in Tertiary Healthcare: A Qualitative Study. BMC Fam Pract (2019) 20(1):165. 10.1186/s12875-019-1053-1

  • 44

    Leigh H Mallios R Stewart D . Teaching Psychiatry in Primary Care Residencies: Do Training Directors of Primary Care and Psychiatry See Eye to Eye?Acad Psychiatry J Am Assoc Dir Psychiatr Resid Train Assoc Acad Psychiatry (2008) 32(6):5049. 10.1176/appi.ap.32.6.504

  • 45

    Carron T Rawlinson C Arditi C Cohidon C Hong QN Pluye P et al An Overview of Reviews on Interprofessional Collaboration in Primary Care: Effectiveness. Int J Integr Care (2021) 21(2):31. 10.5334/ijic.5588

  • 46

    Ambresin G de Roten Y Despland JN . Psychothérapie de la dépression en médecine de premier recours. Swiss Arch Neurol Psychiatry Psychother (2016) 167(05):14754. 10.4414/sanp.2016.00393

  • 47

    Saillant S Marion-Veyron R Oberhauser PN Planas P Ben Cheikh A Tzartzas K . « Group Medical Practices » Project: Collaboration Between Primary Care Medicine and Institutional Public Psychiatry. Rev Med Suisse (2020) 16(704):157981. 10.53738/REVMED.2020.16.704.1579

  • 48

    Référentiel CanMEDS. Référentiel CanMEDS: Le Collège royal des médecins et chirurgiens du Canada (2023). Available from: https://www.royalcollege.ca/rcsite/canmeds/canmeds-framework-f (Accessed January 16, 2023).

  • 49

    Ramos-Sanchez CP Schuch FB Seedat S Louw QA Stubbs B Rosenbaum S et al The Anxiolytic Effects of Exercise for People With Anxiety and Related Disorders: An Update of the Available Meta-Analytic Evidence. Psychiatry Res (2021) 302:114046. 10.1016/j.psychres.2021.114046

  • 50

    Barton J Pretty J . What Is the Best Dose of Nature and Green Exercise for Improving Mental Health? A Multi-Study Analysis. Environ Sci Technol (2010) 44(10):394755. 10.1021/es903183r

  • 51

    Leavell MA Leiferman JA Gascon M Braddick F Gonzalez JC Litt JS . Nature-Based Social Prescribing in Urban Settings to Improve Social Connectedness and Mental Well-Being: A Review. Curr Environ Health Rep (2019) 6(4):297308. 10.1007/s40572-019-00251-7

  • 52

    Younes N Gasquet I Gaudebout P Chaillet MP Kovess V Falissard B et al General Practitioners’ Opinions on Their Practice in Mental Health and Their Collaboration With Mental Health Professionals. BMC Fam Pract (2005) 6(1):18. 10.1186/1471-2296-6-18

  • 53

    Bourmistrova NW Solomon T Braude P Strawbridge R Carter B . Long-Term Effects of COVID-19 on Mental Health: A Systematic Review. J Affect Disord (2022) 299:11825. 10.1016/j.jad.2021.11.031

Summary

Keywords

mental health, general practitioners, anxiety, depression, primary care

Citation

Messer J, Tzartzas K, Marion-Veyron R and Cohidon C (2023) A Cross-Sectional Study of the Prevalence and Determinants of Common Mental Health Problems in Primary Care in Switzerland. Int J Public Health 68:1606368. doi: 10.3389/ijph.2023.1606368

Received

03 July 2023

Accepted

27 November 2023

Published

15 December 2023

Volume

68 - 2023

Edited by

Rana Charafeddine, Scientific Institute of Public Health (WIV-ISP), Belgium

Reviewed by

Eva Rens, University of Antwerp, Belgium

Helena Bruggeman, Sciensano, Belgium

Updates

Copyright

*Correspondence: Juliane Messer,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article